TrialJournal of healthcare engineering2021

Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies.

Yang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.